MemorialCare Cancer Institute
Welcome,         Profile    Billing    Logout  
 6 Trials 
7 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chan, Linda
NCT04644822: Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.

Completed
3
100
Canada
[18F] PSMA-1007 Injection
Centre for Probe Development and Commercialization, McDougall Scientific Ltd.
Prostate Cancer Recurrent, Recurrent Prostate Cancer
01/24
01/24
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Active, not recruiting
3
270
Europe, Canada, US, RoW
NovoTTF-200M device, Best Standard of Care
NovoCure GmbH
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
12/24
12/24
DM-REACH, NCT06382363: Improving T2DM Detection Using Spot cHbA1c Test - a Cluster RCT

Recruiting
N/A
776
RoW
POC-cHbA1c testing
The University of Hong Kong, Hospital Authority, Hong Kong, Food and Health Bureau, Hong Kong
Diabetes Mellitus, Pre-diabetes
09/24
09/24
NCT04552509: TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer

Recruiting
N/A
167
US
Stereotactic Body Radiotherapy
Linda Chan, MD
Prostate Cancer
06/23
06/23
NCT02016248: Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer

Recruiting
N/A
167
US
Stereotactic Ablative Body Radiotherapy as Monotherapy, Accuray CyberKnife, Stereotactic Ablative Body Radiotherapy as a Boost
MemorialCare Health System
Prostate Cancer
06/28
06/29
Zuniga, Javier
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Active, not recruiting
3
270
Europe, Canada, US, RoW
NovoTTF-200M device, Best Standard of Care
NovoCure GmbH
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
12/24
12/24
NCT02016248: Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer

Recruiting
N/A
167
US
Stereotactic Ablative Body Radiotherapy as Monotherapy, Accuray CyberKnife, Stereotactic Ablative Body Radiotherapy as a Boost
MemorialCare Health System
Prostate Cancer
06/28
06/29

Download Options